|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
T�ܰ�ϸ�� |
|
��� |
| ��������������� | |
|
������ |
|
�˾� |
|
����ʤ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
��Ȼɱ��Tϸ����������м�����������е�����
������, �˾�, ����ʤ
�ڶ���ҽ��ѧ����ҽԺƤ����, �Ϻ�200433
��Ȼɱ��Tϸ����һ��ͨ������һЩ������ϸ��������Ӱ���������ϵͳƽ�������ϸ��,������������߹���,�ڶ������������Լ����ķ�������������Ҫ����,���о���Ȼɱ��Tϸ������м�����������е����ý���������
[2] 0rtaldo JR, Winkler-Pickett R, Mason AT, et al. The Ly-49 family:regulation of cytotoxicity and cytokine production in murine CD3 + cells. J Immunol, 1998,160(3):1158-1165.
[3] Eberl G, Lees R, Smiley ST, et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol, 1999, 162(11):6410-6419.
[4] Taniguchi M, Koseki H, Tokuhisa T, et al. Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells. Proc Natl Acad Sci U S A, 1996, 93 (20):11025-11028.
[5] Sato H, Nakayama T, Tanaka Y, et al. Induction of differentiation ofpre-NKT cells to mature Valpha14 NKT cells by granulocyte/macro phage colony-stimulating factor. Proc Natl Acad Sci U S A, 1999, 96 (13):7439-7444.
[6] MacDonald HR. CD1d-glycolipid tetramers:A new tool to monitor natural killer T cells in health and disease. J Exp Med, 2000, 192 (5):F15-20.
[7] Joyce S, Woods AS, Yewdell JW, et al. Natural ligand of mouse CD1 d1:cellular glycosylphosphatidylinositol. Science, 1998, 279 (5356):1541-1544.
[8] Yoshimoto T, Paul WE. CD4pos, NKI. lpos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J ExpMed, 1994, 179(4):1285-1295.
[9] Yoshimoto T, Bendelac A, Watson C, et al. Role of NK1.1 + T cells in a TH2 response and in immunoglobulin E production. Science, 1995, 270(5243):1845-1847.
[10] Kadowaki N, Antonenko S, Ho S, et al. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med, 2001, 193(10):1221-1226.
[11] Burdin N, Brossay L, Kronenberg M. Immunization with alpha-galac tosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol, 1999, 29 (6):2014-2025.
[12] Singh N, Hong S, Scherer DC, et al. Cutting edge:activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol, 1999, 163 (5):2373-2377.
[13] Cui J, Watanabe N, Kawano T, et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med, 1999, 190(6):783-792.
[14] Kitamura H, Iwakabe K, Yahata T,et al. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiat ing effect by inducing interleukin (IL)-12 production by dendriticcells and IL-12 receptor expression on NKT cells. J Exp Med,1999, 189(7):1121-1128.
[15] Tomura M, Yu WG, Ahn HJ, et al. A novel function of Valphal4 + CD4 + NKT cells:stimulation of IL-12 production by antigen-pres enting cells in the innate immune system. J Immunol, 1999, 163 (1):93-101.
[16] Leite-De-Moraes MC, Moreau G, Arnould A, et al. IL-4-produ cing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur J Immunol, 1998, 28(5):1507-1515.
[17] Arase H, Arase N, Saito T. Interferon gamma production by naturalkiller (NK) cells and NK1.1 + T cells upon NKR-P1 cross-linking. J Exp Med, 1996, 183(5):2391-2396.
[18] Austin LM, Ozawa M, Kikuchi T, et al. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, inter feron-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TCI (cytotoxic T lymphocyte) and TH1 effector populations:a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol, 1999, 113 (5):752-759.
[19] Lee PT, Benlagha K, Teyton L, et al. Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med, 2002, 195 (5):637-641.
[20] van der Vliet HJ, yon Blomberg BM, Nishi N, et al. Circulating V (alpha24 +) Vbetal 1 + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol, 2001, 100(2):144-148.
[21] Koreek A, Suranyi A, Szony BJ, et al. CD3 + CD56 + NK T cells are significantly decreased in the peripheral blood of patients with pso riasis. Clin Exp Immunol, 2002, 127(1):176-182.
[22] Nickoloff BJ, Wrone-Smith T, Bonish B, et al. Response of murine and normal human skin to injection of allogeneic blood-derived psoriat ic immunocytes:detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol, 1999, 135(5):546-552.
[23] Nickoloff BJ, Bonish B, Huang BB, et al. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci, 2000, 24(3):212-225.
[24] Bonish B, Jullien D, Dutronc Y, et al. Overexpression of CDld by keratinoeytes in psoriasis and CD1 d-dependent IFN-gamma production by NK-T cells. J Immunol, 2000, 165 (7):4076-4085.